Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2002 1
2003 1
2004 3
2005 1
2006 2
2007 2
2008 1
2009 1
2010 1
2011 1
2015 1
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Tree AC, Hinder V, Chan A, Tolan S, Ostler P, van der Voet H, Kancherla K, Loblaw A, Naismith O, Jain S, Martin A, Price D, Brand D, Chu W, Duffton A, Kelly P, O'Neill B, Staffurth J, Sasso G, Pugh J, Manning G, Brown S, Burnett S, Griffin C, Hall E, van As N; PACE Investigators. Tree AC, et al. Lancet Oncol. 2025 Jul;26(7):936-947. doi: 10.1016/S1470-2045(25)00205-0. Epub 2025 Jun 12. Lancet Oncol. 2025. PMID: 40517778 Free PMC article. Clinical Trial.
Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms.
McIntyre MH, Kantoff PW, Stampfer MJ, Mucci LA, Parslow D, Li H, Gaziano JM, Abe M, Ma J. McIntyre MH, et al. Among authors: parslow d. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2233-6. doi: 10.1158/1055-9965.EPI-07-0481. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18006911
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study.
Baxter MA, Rowe M, Zucker K, Peters AL, Rohan M, Marsh A, Gee AL, Quesne G, Heseltine J, Prichard R, Scott D, O'Neill C, Brunner C, Howells J, Conteh V, Aujayeb A, Yan X, Rodgers LJ, Martin S, Dearden H; NOTCH. Baxter MA, et al. BMJ Oncol. 2024 Aug 29;3(1):e000459. doi: 10.1136/bmjonc-2024-000459. eCollection 2024. BMJ Oncol. 2024. PMID: 39886166 Free PMC article.
UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme.
Daniels H, Hassan M, Babiker O, Rowley W, Qaisar A, Phillips E, Griffin E, Bell C, Baraka B, Acharige S, Aquino M, Plant R, Mencel J, Chan S, Parslow D, Arora A, Scott-Brown M, Khakoo S, Braconi C, Palmer D, Ma YT, Sivakumar S. Daniels H, et al. Among authors: parslow d. Cancers (Basel). 2025 Aug 22;17(17):2732. doi: 10.3390/cancers17172732. Cancers (Basel). 2025. PMID: 40940830 Free PMC article.
18 results